CD36's Role in Malaria Infection
Author Information
Author(s): Cunha-Rodrigues Margarida, Sílvia, Febbraio Maria, Mota Maria M
Primary Institution: Unidade de Malária, Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa
Hypothesis
What is the role of CD36 in the pathology of Plasmodium berghei ANKA infection?
Conclusion
CD36 has both beneficial and adverse effects in Plasmodium berghei ANKA infection, depending on its expression in different cell types.
Supporting Evidence
- Chimeric mice expressing CD36 only in haematopoietic cells showed a 25% survival rate against cerebral malaria.
- Mice with CD36 expression in non-haematopoietic cells all died from experimental cerebral malaria.
- The study suggests that targeting CD36 for malaria treatment needs to be cell-type specific.
Takeaway
This study shows that a protein called CD36 can help fight malaria when it's in certain cells, but it can also cause problems when it's in other cells.
Methodology
The study used CD36-deficient mice and bone marrow chimeric mice to analyze the effects of CD36 expression in different cell types during Plasmodium infection.
Limitations
The study's findings may not fully translate to human malaria due to differences between mouse and human infections.
Participant Demographics
Male CD36-deficient mice and their wild type littermates, aged 7 to 9 weeks.
Statistical Information
P-Value
<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website